Moe, M., Micallef, R., Pwint, T., Maughan, T., Mort, D., & Wagstaff, J. (2008). Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer.
Citación estilo ChicagoMoe, M., R. Micallef, T. Pwint, T. Maughan, D. Mort, and J. Wagstaff. Cetuximab Plus Irinotecan as Third Line Chemotherapy for Metastatic Colorectal Cancer. 2008.
Cita MLAMoe, M., et al. Cetuximab Plus Irinotecan as Third Line Chemotherapy for Metastatic Colorectal Cancer. 2008.
Warning: These citations may not always be 100% accurate.